Iodine Market Size, Share, Growth, and Industry Analysis, By Type (Natural Brines,Nitrite Ores,Others (Seaweed)), By Application (X-Ray Contrast Media,Catalysts,Biocides,LED/LCD Polarizing Films,Feed Additives,Human Nutrition,Pharmaceuticals,Others), Regional Insights and Forecast to 2035

Iodine Market Overview

The global Iodine Market size is projected to grow from USD 1505.54 million in 2026 to USD 1595.42 million in 2027, reaching USD 2536.78 million by 2035, expanding at a CAGR of 5.97% during the forecast period.

The Iodine Market Report shows total global extraction volume at 33,000 metric tons in 2024, with caliche ore, underground brines, and seaweed contributing roughly 50 %, 30 %, and 20 % respectively. Year-on-year consumption for medical imaging (X-Ray Contrast Media) reached 15,000 metric tons, while pharmaceuticals accounted for 8,000 metric tons, and feed additives another 3,500 metric tons. The Iodine Market Analysis highlights that iodine extraction capacity stands above 40,000 metric tons annually, with iodine supply concentrated in Chile and Japan, which together produce over 90 % of total output.

The U.S. Iodine Market Insights estimates domestic production at 2,500 metric tons in 2023, equal to approximately 5 % of global output, primarily sourced from Far West brines in California and Montana. Healthcare and pharmaceutical applications account for roughly 45 % of U.S. iodine consumption, notably for contrast media. The Iodine Market Research Report indicates the Northeast healthcare infrastructure, with over 1,200 hospitals representing 20 % of U.S. hospital count, drives strong diagnostic demand, with local demand increasing by 3.8 % per annum as of latest data.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising demand in medical imaging applications accounts for 27 % of iodine consumption globally, boosting Iodine Market Growth.
• Major Market Restraint: Roughly 22 % of iodine producers cite high extraction cost as a key barrier to expansion.
• Emerging Trends: Iodized salt fortification programs cover 66 % of households globally, enhancing base consumption.
• Regional Leadership: Europe holds 36 % of global iodine demand, securing the top regional position.
• Competitive Landscape: Chile and Japan account for over 90 % of global production, indicating high market concentration.
• Market Segmentation: Caliche ore sources contribute 48 %, underground brines 34 %, seaweed 18 % of total supply.
• Recent Development: LED/LCD polarizing film demand has increased iodine usage by 15 % in optics sector.

Iodine Market Latest Trends

The Iodine Market Trends overview emphasizes that caliche ore extraction contributes 48 % of global iodine supply while underground brines supply 34 %, and seaweed accounts for 18 %, according to the Iodine Market Report. Demand in X-Ray contrast media consumes 27.7 % of the market, boosting iodine use in medical imaging. Iodine-fortified salt now reaches 66 % of global households, preventing deficiency in roughly two billion people, including an estimated 187 million diagnosed goiter cases globally. In Asia-Pacific, iodine deficiency still impacts up to 40 % of populations, especially inland China and certain African regions. 

Iodine Market Dynamics

Iodine market dynamics encompass the drivers, restraints, opportunities, and challenges that guide the industry’s performance and growth trajectory. Demand from pharmaceuticals accounts for nearly 35% of total iodine consumption globally, while healthcare imaging applications such as X-ray contrast media represent around 28% of total use. On the restraint side, approximately 20% of production delays are linked to dependence on natural brines and nitrite ores, which face extraction limitations.

DRIVER

"Rising demand for medical imaging applications."

A primary driver in the Iodine Industry Analysis is that X-Ray and CT contrast media now consume 27.7 % of global iodine supply. Diagnostic imaging centers worldwide use approximately 10,000-15,000 metric tons annually of iodine, emphasizing its vital role in early disease detection. In the U.S., over 1,200 hospitals representing 20 % of the national total are significant iodine consumers. Growth in medical procedures has raised demand by 3.8 % annually in recent years, anchoring sustained procurement volumes.

RESTRAINT

"High extraction and logistics costs."

A significant restraint is that 22 % of iodine producers report that cost of extraction—for caliche ore and brine drilling—limits expansion. In particular, constructing caliche processing units requires capital investment equivalent to several tens of millions. Additionally, seaweed-based extraction remains niche due to lower yield per metric ton and higher processing expense, restricting seaweed’s 18 % supply share. These cost pressures constrain scaling and price competitiveness.

OPPORTUNITY

"Salt iodization and feed fortification."

An opportunity lies in increased iodized salt coverage averaging 66 % of households globally, preventing deficiency after penetrating 66 %. Furthermore, demand for iodine as feed additive has risen by 3,500 metric tons per year, driven by expanding livestock sectors in Asia and Latin America. Opportunities also arise from optical industries, where iodine-based polarizing films now account for 15 % of iodine used in LED/LCD manufacturing.

CHALLENGE

"Regulatory and health compliance."

A key challenge is balancing iodine fortification and overconsumption: Japan previously experienced average daily intake between 1,000–3,000 µg/day, far above standard adult recommended intake of 150 µg/day. Regulatory limits set tolerable upper intake levels between 600–3,000 µg/day, depending on region. Another challenge is managing iodine deficiency affecting up to two billion people, while preventing excessive intake in high-consumption populations like Japan.

Iodine Market Segmentation

The Iodine Market segmentation by type divides supply sources into caliche ore (48 %), underground brines (34 %), and seaweed (18 %). By application, iodine is used in X-Ray contrast media (27.7 % share), pharmaceuticals/nutrition (14 %), feed additives (~10 %), biocides/disinfectants (significant share in hygiene sector), catalysts, polarizing films (15 % share in optics), and other industrial uses. This segmentation helps stakeholders understand supply and demand alignment across applications and sourcing, as captured in Iodine Market Research Report, Market Outlook, and Market Opportunities.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Natural Brines (Underground Brines): Underground brine sources provide approximately 34 % of global iodine supply, with extraction volumes around 11,200 metric tons annually. Key brine-producing regions like California and Montana in the U.S. deliver roughly 2,500 metric tons domestically, accounting for about 5 % of global output. Brine extraction facilities typically produce iodine concentrations around 100–250 mg/L, with annual retrieval rates reaching thousands of liters of saturated brine. 

The Natural Brines segment is estimated at USD 681.95 million in 2025, representing 48.0% global share, and is forecast to expand at a 6.10% CAGR through 2034, supported by stable brine fields and diversified industrial offtake contracts.

Top 5 Major Dominant Countries in the Natural Brines Segment

• United States: 2025 size USD 190.95 million in Natural Brines, equal to 28.0% segment share, advancing at 6.2% CAGR to 2034 on mature brine assets, diagnostic imaging demand, and resilient chemical value chains.
• Japan: 2025 size USD 150.03 million, holding 22.0% segment share, growing at 5.9% CAGR through 2034 as specialty chemicals, polarizing films, and nutrition applications maintain consistent consumption.
• Turkmenistan: 2025 size USD 81.83 million, 12.0% segment share, projected at 6.1% CAGR to 2034 with upstream brine development, pipeline tie-ins, and regional processing expansions.
• Azerbaijan: 2025 size USD 68.20 million, contributing 10.0% share, increasing at 5.7% CAGR through 2034 on brownfield upgrades, brine productivity improvements, and diversified industrial orders.
• China: 2025 size USD 54.56 million, 8.0% segment share, rising at 6.4% CAGR to 2034 as healthcare systems, feed mills, and iodization initiatives expand domestic consumption.

Nitrite Ores (Caliche Ore): Caliche ore extraction dominates the Iodine Market, delivering 48 % of global production, or approximately 15,840 metric tons annually. Chile and Japan lead caliche mining, together producing more than 90 % of global output. Caliche contains iodine concentrations around 1,000–2,000 ppm, enabling industrial-scale processing. Extraction volume per mine often exceeds 1,500 metric tons yearly, with multiple active mines maintaining capacity. 

The Nitrite Ores segment (caliche-derived) is valued at USD 483.04 million in 2025, accounting for 34.0% market share, and is projected to advance at a 5.80% CAGR to 2034 as large open-pit operations sustain high-purity output.

Top 5 Major Dominant Countries in the Nitrite Ores Segment

• Chile: 2025 size USD 289.82 million, equal to 60.0% of the Nitrite Ores segment, increasing at 6.0% CAGR to 2034 on capacity additions, high-grade ore runs, and secured offtake to imaging producers.
• Peru: 2025 size USD 48.30 million, 10.0% segment share, growing at 5.7% CAGR through 2034 as nitrate-rich deposits support regional chemical supply chains and new beneficiation units.
• Argentina: 2025 size USD 38.64 million, 8.0% share, projected at 5.9% CAGR to 2034 with exploration programs, logistics corridor upgrades, and selective ore blending strategies.
• China: 2025 size USD 33.81 million, 7.0% share, expanding at 6.1% CAGR through 2034 as domestic conversion units balance imports with local ore processing.
• Russia: 2025 size USD 24.15 million, 5.0% share, advancing at 5.6% CAGR to 2034 on industrial diversification and selective ore-to-iodine projects.

Others (Seaweed): Seaweed-based iodine extraction contributes about 18 % to global supply, roughly 6,000 metric tons annually, mainly sourced from kelp harvesting in East Asia. Extraction yields per ton of wet seaweed range between 0.1–0.3% iodine content, with batch volumes of 10–50 metric tons per harvest. Seaweed supply is subject to seasonal and ecological constraints, with annual fluctuations of ±10 % in yield. 

The Others (Seaweed) segment totals USD 255.73 million in 2025, holding 18.0% global share, and is anticipated to grow at a 6.20% CAGR to 2034, benefiting from nutraceuticals and premium food-grade formulations.

Top 5 Major Dominant Countries in the Others (Seaweed) Segment

• Japan: 2025 size USD 71.60 million, 28.0% segment share, growing at 5.8% CAGR to 2034 as kelp harvesting and high-purity processing serve supplements and pharma excipients.
• China: 2025 size USD 56.26 million, 22.0% share, increasing at 6.3% CAGR through 2034 with coastal aquaculture, fortified foods, and regional healthcare procurement.
• Indonesia: 2025 size USD 46.03 million, 18.0% share, rising at 6.6% CAGR to 2034 on large-scale seaweed cultivation, drying capacity, and downstream iodine derivatives.
• Philippines: 2025 size USD 25.57 million, 10.0% share, projected at 6.1% CAGR through 2034 as marine biomass programs scale and export contracts deepen.
• South Korea: 2025 size USD 20.46 million, 8.0% share, advancing at 5.9% CAGR to 2034 with functional foods, clinical formulations, and controlled-supply sea farms.

BY APPLICATION

X-Ray Contrast Media: X-Ray Contrast Media consumes approximately 27.7 % of the global iodine supply, equating to 9,100 metric tons annually. Usage is heavily concentrated in diagnostic imaging—CT scans, MRIs, and angiography—utilized by 1,200 U.S. hospitals alone, which account for 20 % of national medical imaging centers. Global demand for contrast applications continues to rise due to aging populations and healthcare infrastructure expansions, especially in Asia. 

2025 application size USD 397.80 million, equal to 28.0% share, expected to expand at 6.2% CAGR to 2034 on rising diagnostic procedures, hospital imaging capacities, and precision-grade iodine procurement.

Top 5 Dominant Countries in X-Ray Contrast Media

• United States: USD 87.52 million, 22.0% application share, 6.3% CAGR to 2034 as large hospital networks and outpatient diagnostic centers sustain high-purity iodine demand.
• China: USD 79.56 million, 20.0% share, 6.5% CAGR through 2034 with healthcare expansion and provincial imaging upgrades.
• Germany: USD 47.74 million, 12.0% share, 5.9% CAGR as contrast usage scales across radiology hubs and academic hospitals.
• Japan: USD 39.78 million, 10.0% share, 5.8% CAGR supported by aging populations and advanced imaging protocols.
• India: USD 31.82 million, 8.0% share, 6.6% CAGR with rapid growth in private radiology chains and tertiary care centers.

Catalysts (Polymer Processing): Iodine serves as a catalyst in polymer synthesis, accounting for approximately 5 % of usage. Industrial polymer plants deploy iodine concentrations between 0.1–0.5 wt %, with annual consumption per facility ranging from 2–50 metric tons. Sectors such as photovoltaic PV cell manufacturing may use specialized iodine catalysts. 

2025 size USD 56.83 million, 4.0% share, advancing at 5.4% CAGR through 2034 as polymerization, specialty synthesis, and photovoltaic processes increase iodine catalyst utilization.

Top 5 Dominant Countries in Catalysts

• United States: USD 13.64 million, 24.0% share, 5.5% CAGR on specialty polymers and process intensification projects.
• China: USD 11.37 million, 20.0% share, 5.7% CAGR with expanding chemical parks and integrated catalyst lines.
• Germany: USD 5.68 million, 10.0% share, 5.2% CAGR driven by performance materials and precision synthesis.
• Japan: USD 4.55 million, 8.0% share, 5.1% CAGR as electronics materials pipelines broaden.
• Netherlands: USD 3.41 million, 6.0% share, 5.0% CAGR with advanced catalyst R&D and contract manufacturing.

Biocides (Disinfectants): Biocidal uses of iodine, including water disinfection and hospital sanitization, account for approximately 8 % of demand, around 2,600 metric tons annually. Hospitals and clean-room users may consume up to 50 kg per site annually. Iodine-based disinfectants are valued for broad antimicrobial efficacy. Usage increased sharply during recent public health surges, with market spikes of 15 % in certain years. 

2025 size USD 99.45 million, 7.0% share, projected at 5.6% CAGR to 2034 as disinfection, water treatment, and healthcare hygiene applications normalize at elevated baseline adoption.

Top 5 Dominant Countries in Biocides

• United States: USD 21.88 million, 22.0% share, 5.7% CAGR with hospital and industrial sanitation standards.
• Germany: USD 15.91 million, 16.0% share, 5.4% CAGR as regulated disinfectant portfolios mature.
• United Kingdom: USD 9.95 million, 10.0% share, 5.3% CAGR driven by clinical, institutional, and municipal hygiene.
• China: USD 17.90 million, 18.0% share, 5.9% CAGR with expanding water treatment plants and healthcare facilities.
• France: USD 7.96 million, 8.0% share, 5.2% CAGR under strong sanitary compliance regimes.

LED/LCD Polarizing Films: Polarizing film production for screens constitutes approximately 15 % of iodine demand, translating into 4,950 metric tons per year. The electronics industry uses iodine compounds in film layers for brightness enhancement. Manufacturing plants in China and South Korea account for 70 % of polarizing film production. Usage per display sheet ranges from 0.5–1 g of iodine, with annual unit output in billions of devices. This application is pivotal in Iodine Market Growth narratives tied to consumer electronics expansion.

2025 size USD 213.11 million, 15.0% share, expected to grow at 6.1% CAGR to 2034 as display manufacturing centers scale polarizer output for consumer electronics and automotive infotainment.

Top 5 Dominant Countries in LED/LCD Polarizing Films

• China: USD 76.72 million, 36.0% share, 6.4% CAGR led by mega-fabs and vertically integrated film lines.
• South Korea: USD 51.15 million, 24.0% share, 6.0% CAGR with advanced display clusters.
• Japan: USD 38.36 million, 18.0% share, 5.8% CAGR under premium optics and materials science leadership.
• Taiwan: USD 21.31 million, 10.0% share, 6.1% CAGR driven by flexible and mid-size panels.
• Vietnam: USD 12.79 million, 6.0% share, 6.3% CAGR as EMS ecosystems expand panel assembly.

Feed Additives (Animal Nutrition): Animal feed additive applications use roughly 10 % of iodine powder, totaling about 3,300 metric tons annually. Guidelines for livestock typically require feed iodine levels between 0.5–2 mg/kg. Major feed mills in India and Brazil produce 100,000+ metric tons of fortified feed annually. These additives support animal health and nutrition, especially in poultry and swine sectors. This segment is spotlighted in Iodine Market Research Report by value and volume of feed fortification trends.

2025 size USD 142.07 million, 10.0% share, increasing at 6.0% CAGR through 2034 as poultry, swine, and dairy premixes standardize iodine inclusion rates.

Top 5 Dominant Countries in Feed Additives

• China: USD 28.41 million, 20.0% share, 6.2% CAGR supported by large feed mills and livestock operations.
• United States: USD 22.73 million, 16.0% share, 5.8% CAGR with integrated protein producers.
• Brazil: USD 17.05 million, 12.0% share, 6.1% CAGR as export-oriented meat chains expand.
• India: USD 14.21 million, 10.0% share, 6.3% CAGR with organized dairy and poultry capacity.
• Russia: USD 11.37 million, 8.0% share, 5.7% CAGR under mixed-feed industrialization.

Human Nutrition (Iodized Salt, Supplements): Human nutrition—through iodized salt and supplements—accounts for approximately 20 % of iodine usage, near 6,600 metric tons annually. Global iodized salt coverage stands at 66 % of households, providing daily intake for roughly two billion people. Recommended Daily Intake (RDA) is 150 µg/day, with tolerable upper limits ranging from 600 to 3,000 µg/day depending on country. 

2025 size USD 284.14 million, 20.0% share, advancing at 5.5% CAGR to 2034, led by iodized salt penetration and supplement programs across populous regions.

Top 5 Dominant Countries in Human Nutrition

• India: USD 62.51 million, 22.0% share, 5.7% CAGR as iodization and retail packs extend coverage.
• China: USD 56.83 million, 20.0% share, 5.6% CAGR with fortified salt and wellness lines.
• Indonesia: USD 22.73 million, 8.0% share, 5.8% CAGR amid mass-market distribution.
• Nigeria: USD 17.05 million, 6.0% share, 5.5% CAGR on public-health procurement.
• Brazil: USD 19.89 million, 7.0% share, 5.6% CAGR under packaged-food fortification.

Pharmaceuticals (Other Medications): Beyond contrast media, pharmaceuticals consume an additional 14 % of iodine supply, approximately 4,620 metric tons annually. Iodine is used in thyroid treatments like levothyroxine and antiseptic formulations. Hospitals may stock 5–10 kg per department of iodine compounds. Pharmaceutical-grade iodine purity exceeds 99 %, with batch sizes around 100–500 kg. 

2025 size USD 198.90 million, 14.0% share, projected at 5.9% CAGR to 2034 as thyroid therapies and antiseptic actives sustain volume.

Top 5 Dominant Countries in Pharmaceuticals

• United States: USD 47.74 million, 24.0% share, 6.0% CAGR with broad prescription bases and hospital demand.
• China: USD 35.80 million, 18.0% share, 6.1% CAGR supported by formulary expansion.
• India: USD 29.84 million, 15.0% share, 6.2% CAGR via generics and export APIs.
• Japan: USD 19.89 million, 10.0% share, 5.7% CAGR in mature hospital channels.
• Germany: USD 17.90 million, 9.0% share, 5.6% CAGR with stable therapeutic usage.

Others (Industrial, Laboratory, Miscellaneous): The remaining 5–8 % of iodine use—around 1,650 metric tons annually—is spread across industrial and laboratory applications. Analytical labs use iodine solutions in titrations, while specialty paints and coatings include iodine derivatives at levels of 1–5% per formula, equating to 2–20 kg per production run. 

2025 size USD 28.41 million, 2.0% share, forecast at 5.2% CAGR to 2034 across lab reagents, coatings, and niche industrial chemistries.

Top 5 Dominant Countries in Others

• United States: USD 6.25 million, 22.0% share, 5.3% CAGR on R&D and specialty lines.
• China: USD 5.68 million, 20.0% share, 5.4% CAGR with diversified small-lot buyers.
• Germany: USD 3.41 million, 12.0% share, 5.1% CAGR across analytical markets.
• India: USD 2.84 million, 10.0% share, 5.5% CAGR as labs and pilot plants scale.
• United Kingdom: USD 2.27 million, 8.0% share, 5.0% CAGR in institutional procurement.

Regional Outlook for the Iodine Market

The Iodine Market is regionally concentrated: Europe holds 36 % of global demand—around 12,000 metric tons annually; Asia-Pacific accounts for 34 %, approximately 11,300 metric tons; North America captures 20 %, about 6,600 metric tons; while Middle East & Africa accounts for 10 %, near 3,300 metric tons of usage. Latin America fills the remaining ? — split across feed and nutrition verticals. These figures inform Iodine Market Share analysis and regional segmentation insights.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America’s Iodine Market accounts for approximately 20 % of global demand, equal to 6,600 metric tons annually. U.S. production based on underground brine extraction reaches 2,500 metric tons or 5 % of global output. Healthcare and pharmaceuticals drive 45 % of consumption. Contrast media consume about 1,830 metric tons. Dietary nutrition and iodized salt intake account for 15 %, or 990 metric tons. Industrial and catalyst applications add another 10 % (~660 metric tons). 

North America’s iodine market totals USD 312.56 million in 2025, equaling 22.0% global share, projected to grow at a 5.6% CAGR to 2034 on brine output stability, imaging usage, and feed additive standardization.

North America – Major Dominant Countries in the “Iodine Market”

• United States: USD 243.80 million, 78.0% regional share, 5.7% CAGR to 2034 with strong healthcare, polymer catalysts, and iodized nutrition programs.
• Canada: USD 37.51 million, 12.0% share, 5.4% CAGR supported by pharmaceuticals and fortified foods.
• Mexico: USD 25.00 million, 8.0% share, 5.8% CAGR with processing plants and feed integrators.
• Cuba: USD 3.13 million, 1.0% share, 5.1% CAGR via nutrition coverage expansion.
• Dominican Republic: USD 3.13 million, 1.0% share, 5.2% CAGR under fortified salt penetration.

EUROPE

Europe dominates global iodine demand at 36 %, equal to 12,000 metric tons annually. Caliche ore imports dominate, as local mining is limited. Contrast media usage consumes 3,300 metric tons, while human nutrition, through iodized salt, uses 2,400 metric tons. Feed additives account for 1,200 metric tons, and pharmaceuticals for 1,680 metric tons. Polarizing films demand adds around 1,800 metric tons, particularly due to Germany and South Korea’s manufacturing partnerships.

Europe is USD 397.80 million in 2025, accounting for 28.0% global share, expected to advance at a 5.5% CAGR to 2034 across contrast media hubs, pharmaceutical clusters, and regulated iodization.

Europe – Major Dominant Countries in the “Iodine Market”

• Germany: USD 111.38 million, 28.0% regional share, 5.6% CAGR with medical imaging and performance materials.
• United Kingdom: USD 79.56 million, 20.0% share, 5.5% CAGR driven by biocides and healthcare purchases.
• France: USD 63.65 million, 16.0% share, 5.4% CAGR across pharma and nutrition channels.
• Italy: USD 47.74 million, 12.0% share, 5.3% CAGR with food fortification and clinical demand.
• Spain: USD 39.78 million, 10.0% share, 5.2% CAGR on industrial and hospital usage.

ASIA-PACIFIC

Asia-Pacific represents 34 % of global iodine demand (~11,300 metric tons annually). China and India account for two-thirds: China uses 6,800 metric tons, India 2,900 metric tons. Contrast media utilization consumes 3,500 metric tons; nutrition and iodized salt account for 3,100 metric tons, thanks to expanded salt iodization programs. Feed additives represent 1,500 metric tons, driven by growing livestock farms. Pharmaceuticals consume 1,600 metric tons, while optics (polarizing films) account for 1,200 metric tons. 

Asia reaches USD 568.29 million in 2025, equal to 40.0% global share, poised for 6.4% CAGR to 2034 through expansive healthcare, iodization programs, and display manufacturing ecosystems.

Asia – Major Dominant Countries in the “Iodine Market”

• China: USD 295.51 million, 52.0% regional share, 6.5% CAGR on contrast media, polarizers, and fortified foods.
• India: USD 113.66 million, 20.0% share, 6.6% CAGR via nutrition and pharma scaling.
• Japan: USD 56.83 million, 10.0% share, 5.8% CAGR with seaweed-based derivatives and medical applications.
• South Korea: USD 45.46 million, 8.0% share, 6.2% CAGR tied to display supply chains.
• Indonesia: USD 34.10 million, 6.0% share, 6.3% CAGR with iodized salt reach and aquaculture feed.

MIDDLE EAST & AFRICA

Middle East & Africa (MEA) comprise approximately 10 % of global iodine demand (~3,300 metric tons annually). Saudi Arabia and UAE together account for 1,200 metric tons, primarily for pharmaceuticals and nutrition. Feed additives (livestock) use 500 metric tons, while contrast media demand in regional hospitals accounts for 700 metric tons. Human nutrition through iodized salt covers 800 metric tons, with iodization programs reaching 70 % of households. 

Middle East and Africa total USD 142.07 million in 2025, representing 10.0% share, projected at a 5.8% CAGR to 2034 as public health fortification and pharma logistics expand regional offtake.

Middle East and Africa – Major Dominant Countries in the “Iodine Market”

• Saudi Arabia: USD 39.78 million, 28.0% regional share, 5.9% CAGR with hospital imaging and fortified staples.
• United Arab Emirates: USD 28.41 million, 20.0% share, 6.0% CAGR across pharma distribution and specialty foods.
• South Africa: USD 25.57 million, 18.0% share, 5.6% CAGR in nutrition, biocides, and clinical channels.
• Egypt: USD 19.89 million, 14.0% share, 5.7% CAGR supported by iodization and hospital procurement.
• Nigeria: USD 14.21 million, 10.0% share, 5.8% CAGR as fortified food coverage widens and feed demand rises.

List of Top Iodine Companies

• Wengfu
• Iofina
• KNG
• Ise Chemicals
• Algorta Norte SA
• RB Energy
• Nippoh Chemicals Co
• GODO SHIGEN
• Toho Earthtech
• SQM
• Gather Great Ocean
• Cosayach
• IOCHEM Corporation

Wengfu — accounts for approximately 25 % of global iodine production, particularly from caliche mining.

Iofina — holds around 20 % of production share via brine extraction technologies, focusing on high-purity iodine for imaging.

Investment Analysis and Opportunities

Investment flows in the Iodine Market heavily target supply expansion and extraction tech: 30 % of capital expenditure in recent years supports new caliche mine operations, while 20 % funds brine extraction infrastructure. Strategic investments in seaweed-based extraction are growing, reaching 5 % of total project funding, often for supplements or food-grade supply. Nutrition and public-health initiatives fund roughly 15 % of global iodization programs, especially in Asia and Africa, to combat deficiency in up to two billion people. Feed additive sectors receive 10 % of investment, mainly to support growing poultry and livestock sectors across Latin America and Asia. 

New Product Development

New product innovations in the Iodine Market include LED-grade high-purity iodine compounds, comprising 10 % of recent product launches, featuring ≥99.99 % purity. Development of seaweed-derived supplement formulations, delivering 500 µg per serving, accounts for 5 % of new products aimed at wellness markets. Pharmaceutical-grade lactose-free contrast formulations using nanoparticulate iodine now constitute 8 % of R&D outputs, targeting improved bioavailability. Iodized salt packages with microencapsulation technologies maintaining 25 mg/kg concentration—up to 80 % retention after six months—represent 7 % of new consumer products. 

Five Recent Developments

• Chile expanded a caliche ore operation in 2024 by 2,000 metric tons annual capacity, raising national output by 10 %.
• Iofina commissioned a new brine extraction facility in 2025 delivering 500 metric tons per year of high-purity iodine.
• European research consortium launched a pilot iodine supplementation program in 2023 reaching 10 million people, covering 15 % of the targeted population.
• A Japanese electronics firm developed a high-purity iodine compound for polarizing film in 2024, reducing impurity levels by 50 %.
• A Middle East public health initiative increased iodized salt coverage from 50 % to 70 % within one year (2024), as part of a nutrition drive.

Report Coverage of Iodine Market

The Iodine Market Report offers exhaustive scope across supply sources, applications, and regions. It details extraction volumes—caliche ore (48 %), brines (34 %), seaweed (18 %)—and application shares, including contrast media (27.7 %), human nutrition (20 %), pharmaceuticals (14 %), optics (15 %), feed additives (10 %), biocides, catalysts, and others. Regional coverage extends to Europe (36 %), Asia-Pacific (34 %), North America (20 %), MEA (10 %), with volume and consumption patterns for each region quantified in metric tons. The report includes company share insights, noting Wengfu (25 %) and Iofina (20 %) as dominant producers. 

Iodine Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1505.54 Million in 2026
Market Size Value By	USD 2536.78 Million by 2035
Growth Rate	CAGR of 5.97% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Natural Brines Nitrite Ores Others (Seaweed) By Application : X-Ray Contrast Media Catalysts Biocides LED/LCD Polarizing Films Feed Additives Human Nutrition Pharmaceuticals Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample